What is Intagras?
Intagras specializes in providing advanced regulatory tracking and submission solutions tailored for the pharmaceutical industry. Their core offerings include the Tracking Portal and SPL Portal, designed to streamline structured product labeling and ensure compliance with global regulatory standards. By automating markup for submissions and offering comprehensive tracking of safety and compliance data, Intagras empowers pharmaceutical companies and their regulatory teams to navigate complex compliance landscapes more efficiently. Beyond their software solutions, the company also provides expert outsourcing services to further enhance operational efficiency and regulatory adherence.
How much funding has Intagras raised?
Intagras has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Intagras
PPP
Public-Private Partnership
What's next for Intagras?
With a substantial late-stage funding context, Intagras is poised for significant scaling and market expansion. The recent strategic investment likely signals confidence from investors in the company's proven track record and its capacity to address the evolving demands of global regulatory compliance. Future initiatives may focus on enhancing their existing product suite, expanding into new geographical markets, and potentially developing new solutions to further simplify the intricate process of regulatory submissions and tracking for life sciences organizations.
See full Intagras company page
